Parallax Volatility Advisers, L.P. Abbott Laboratories Put Options Transaction History

Parallax Volatility Advisers, L.P.

$53.5 Billion
Q3 2024

Put Options

26 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $4.73 Million - $5.59 Million	47,300 Added 198.74%	71,100 $8.11 Million
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $130,949 - $146,172	1,300 Added 5.78%	23,800 $2.47 Million
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $1.69 Million - $1.86 Million	15,400 Added 216.9%	22,500 $2.56 Million
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $586,235 - $717,600	6,500 Added 1083.33%	7,100 $781,000
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $1.23 Million - $1.48 Million	-12,900 Reduced 95.56%	600 $58,000
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $9.65 Million - $10.8 Million	-95,800 Reduced 87.65%	13,500 $1.47 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $6.32 Million - $7.44 Million	-65,300 Reduced 37.4%	109,300 $11.1 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $10.3 Million - $12 Million	107,900 Added 161.77%	174,600 $19.2 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $5.26 Million - $6.09 Million	54,400 Added 442.28%	66,700 $6.45 Million
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $6.06 Million - $7.33 Million	-59,400 Reduced 82.85%	12,300 $1.34 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $23.2 Million - $28.3 Million	-203,300 Reduced 73.93%	71,700 $8.49 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $6.75 Million - $8.26 Million	58,400 Added 26.96%	275,000 $38.7 Million
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $9.54 Million - $10.6 Million	81,800 Added 60.68%	216,600 $25.6 Million
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $14.2 Million - $16.8 Million	134,600 Added 67300.0%	134,800 $15.6 Million
Q1 2021 May 14, 2021	SELL	$108.84 - $128.23 $24.9 Million - $29.3 Million	-228,500 Reduced 99.91%	200 $24,000
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $41.4 Million - $45.1 Million	-394,000 Reduced 63.27%	228,700 $25 Million
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $21.7 Million - $26.4 Million	237,000 Added 61.45%	622,700 $67.8 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $2.79 Million - $3.57 Million	36,400 Added 10.42%	385,700 $35.3 Million
Q1 2020 May 15, 2020	BUY	$62.82 - $91.86 $6.8 Million - $9.95 Million	108,300 Added 44.94%	349,300 $27.6 Million
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $4.37 Million - $4.86 Million	55,600 Added 29.99%	241,000 $20.9 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $4.66 Million - $5.06 Million	-57,000 Reduced 23.51%	185,400 $15.5 Million
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $11 Million - $12.8 Million	150,400 Added 163.48%	242,400 $20.4 Million
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $7.79 Million - $9.42 Million	-117,700 Reduced 56.13%	92,000 $7.36 Million
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $3.33 Million - $3.77 Million	50,800 Added 31.97%	209,700 $15.2 Million
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $6.48 Million - $7.81 Million	106,500 Added 203.24%	158,900 $11.7 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $2.52 Million - $2.81 Million	52,400	52,400 $2.8 Million

Others Institutions Holding ABT

# of Institutions

3,184

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19.5 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15.2 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$8.89 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.62 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.18 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.

Account